Anti-NMDA-receptor encephalitis: case series and analysis of the effects of antibodiesJosep Dalmau, David R. Lynch, Amy J. Gleichman et al.|The Lancet Neurology|2008Cited by 3.5k
Treatment and prognostic factors for long-term outcome in patients with anti-NMDA receptor encephalitis: an observational cohort studyMaarten J. Titulaer, Josep Dalmau, Albert Saiz et al.|The Lancet Neurology|2013Cited by 3.1k
Clinical experience and laboratory investigations in patients with anti-NMDAR encephalitisJosep Dalmau, Rita J. Balice‐Gordon, Eric Lancaster et al.|The Lancet Neurology|2010Cited by 2.4k
Investigation of LGI1 as the antigen in limbic encephalitis previously attributed to potassium channels: a case seriesMeizan Lai, Josep Dalmau, Maartje G. Huijbers et al.|The Lancet Neurology|2010Cited by 1.4k
Antibody titres at diagnosis and during follow-up of anti-NMDA receptor encephalitis: a retrospective studyNúria Gresa‐Arribas, Josep Dalmau, Maarten J. Titulaer et al.|The Lancet Neurology|2013Cited by 1.3k